Safety, Tolerability, and Immunogenicity of the Ebola Sudan Chimpanzee Adenovirus Vector Vaccine (Cad3-Ebo S) in Healthy Ugandan Adults: a Phase 1, Open-Label, Dose-Escalation Clinical Trial. Betty Mwesigwa , Katherine Houser , Amelia R. Hofstetter , Ana M. Ortega-Villa , Prossy Naluyima , Francis Kiweewa , Immaculate Nakabuye , Galina Yamshchikov , Charla Andrews , Mark O'Callahan , Larisa Strom , Steven Schech , Leigh Anne Eller , Erica L. Sondergaard , Paul T. Scott , Mihret F. Amare , Kayvon Modjarrad , Amir Wamala , Allan Tindikahwa , Ezra Musingye , Jauhara Nanyondo , Martin R. Gaudinski , Ingelise J. Gordon , LaSonji A. Holman , Jamie G. Saunders , Pamela J. M. Costner , Floreliz H. Mendoza , Myra Happe , Patricia Morgan , Sarah H. Plummer , Somia P. Hickman , Sandra Vazquez , Tamar Murray , Jamilet Cordon , Caitlyn N. M. Dulan , Ruth Hunegnaw , Manjula Basappa , Marcelino Padilla , Suprabhath R. Gajjala , Phillip A. Swanson II , Bob C. Lin , Emily E. Coates , Jason G. Gall , Adrian B. McDermott , Richard A. Koup , John R. Mascola , Aurelie Ploquin , Nancy J. Sullivan , Hannah Kibuuka , Julie A. Ake , Julie E. Ledgerwood Lancet Infectious diseases/The Lancet Infectious diseases（2023）
AI 理解论文
溯源树
样例
